Summary: Researchers have received a five-year, $3.2 million grant from the U.S. National Institutes of Health’s National Institute of Mental Health to investigate the epigenetic networks in the amygdala that create persistent biological memories of trauma. The project aims to identify molecular changes that drive exaggerated fear responses in post-traumatic stress disorder (PTSD) and to develop strategies to manipulate those changes for better, sex-informed treatments.
Using a combination of histone profiling, focused study of the histone modifier HDAC3, high-throughput RNA sequencing, ChIP-seq, and CRISPR/Cas9 gene editing, the multi-institutional team plans to map the molecular signature of trauma in the brain’s fear center, test causal roles for candidate genes, and explore approaches to reverse or attenuate pathological fear memories.
Key Facts
- The PTSD challenge: An estimated 7% of people in the United States will experience PTSD in their lifetime. PTSD is characterized by enduring biological changes that produce hyper-vigilant and exaggerated fear responses, and currently there is no single treatment that reliably helps all patients.
- Amygdala-focused epigenetics: The team uses a conserved mouse model to isolate the amygdala—the brain region central to fear—and study how histones, the proteins that package DNA, are epigenetically modified during traumatic events. These changes alter gene accessibility without changing DNA sequence, producing long-lasting effects on gene expression.
- Primed molecular memory hypothesis: Led by Dr. Janine Kwapis, the researchers propose that trauma leaves specific epigenetic marks on genes that control fear memory, keeping those genes in a hyper-accessible state. This “primed” state may cause a small later stressor to elicit an outsized fear response because the relevant genes can be expressed very rapidly.
- HDAC3 as a fear regulator: Prior work from the team identified HDAC3, a histone deacetylase, as a regulator of memory formation during stress. Experimentally blocking HDAC3 during a mild stressor can make the brain store that minor event as if it were a major trauma, suggesting HDAC3 plays a key role in how traumatic memories are encoded.
- Genome-wide discovery and manipulation: Co-investigator Dr. Istvan Albert will use RNA sequencing and ChIP-seq to find genes and genomic regions altered by stress. Top candidate genes and regulatory elements will then be tested with CRISPR/Cas9 editing to determine their causal roles in producing exaggerated fear.
- Sex differences in vulnerability: Women are roughly twice as likely as men to develop PTSD. Co-investigator Dr. Karyn Frick reports that female mice show stronger, longer-lasting fear responses to mild stressors than male mice. The grant will investigate whether females have a lower biological threshold for forming traumatic molecular memories or whether other mechanisms explain the sex disparity.
Source: Penn State
Background: A single traumatic experience can produce durable biological alterations that change how the brain responds to subsequent stress. These alterations can cause normal survival responses to become excessive, as seen in PTSD and related anxiety disorders. To clarify the molecular events that create these persistent changes, researchers at Penn State and the University of Wisconsin–Milwaukee are combining genetic, biochemical, and behavioral tools supported by this NIH-funded grant.
The project centers on the amygdala, a highly conserved brain structure that gates fear memory. By studying histone modifications in mouse models, the team will examine how histones loosen or tighten around DNA to make specific genes more or less available to the cellular transcription machinery. These epigenetic modifications do not alter the DNA sequence but do change gene expression patterns in ways that can last long after the traumatic event.
Kwapis and colleagues hypothesize that trauma imprints a molecular memory: specialized epigenetic marks that prime fear-related genes to respond rapidly if another stressor occurs. While such priming could be adaptive in some circumstances, when overactive it may produce the pathological, frequent, or intense fear responses that impair daily functioning in PTSD.
Previous experiments from the group implicate the histone modifier HDAC3 in stress-related memory encoding. Blocking HDAC3 during a mild and otherwise insignificant stressor caused animals to encode that event as a strong traumatic memory. Building on that insight, the current project aims to identify other epigenetic regulators and gene targets that together establish and maintain trauma-related molecular memories.
The research strategy uses RNA sequencing to catalog genes overexpressed in the amygdala after stress, and ChIP-seq to localize histone modifications across the genome. The combined datasets will be cross-referenced to prioritize candidates for functional testing. CRISPR/Cas9 will then be used to manipulate those genes or regulatory elements to evaluate whether altering them prevents or reverses exaggerated fear behaviors.
A central objective is to understand sex differences in vulnerability to PTSD. Laboratory data show that female mice often develop stronger and longer-lasting fear memories than males after the same mild stimuli. The team will test whether females require less stress input to form persistent molecular marks or whether distinct molecular pathways underlie their heightened sensitivity.
Beyond trauma and PTSD, the findings could illuminate mechanisms common to other anxiety disorders in which the brain overreacts to everyday stresses. If researchers can precisely map and manipulate the molecular memory of trauma, it may open paths to targeted, sex-informed therapies that reduce or erase pathological fear memories.
Key Questions Answered:
A: Trauma can create a physical “molecular memory” in the amygdala through epigenetic changes. Histones remodel how DNA is packaged, leaving specific fear-response genes more exposed and primed for rapid activation. That primed state can make otherwise minor stressors trigger exaggerated fear responses by enabling faster, stronger gene expression.
A: HDAC3 is a histone-modifying enzyme involved in editing chromatin states during memory formation. In experimental settings, blocking HDAC3 during a mild stressor caused animals to store that event as a potent traumatic memory, suggesting HDAC3 helps regulate whether an experience becomes strongly encoded.
A: Epidemiological data show women are about twice as likely to develop PTSD as men, but the biological reasons are unclear. In animal models, females often form stronger fear memories to the same stimuli. The grant supports systematic investigation of sex-specific thresholds and molecular mechanisms that could explain this disparity.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this genetics, PTSD, and memory research news
Author: Adrienne Berard
Source: Penn State
Contact: Adrienne Berard – Penn State
Image: The image is credited to Neuroscience News